Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Fecal Microbiota Transplantation in Patients Co-Infected with SARS-CoV2 and .

< BACK TO ARCHIVE


2022 Dec 21


Biomedicines


http://www.ncbi.nlm.nih.gov/pubmed/36672518?dopt=Abstract


11


1

Fecal Microbiota Transplantation in Patients Co-Infected with SARS-CoV2 and .

Authors

Fecal Microbiota Transplantation in Patients Co-Infected with SARS-CoV2 and .
Boicean A, Neamtu B, Birsan S, Batar F, Tanasescu C, Dura H, Roman M D, Hașegan A, Bratu D, Mihetiu A, Mohor C I, Mohor C, Bacila C, Negrea M O, Fleaca S R
Biomedicines. 2022 Dec 21; 11(1).
PMID: 36672518.

Abstract

The COVID-19 pandemic has challenged the treatment of (CD)-infected patients given the increasing number of co-infections with 2 (SARS-CoV-2). In this context, fecal microbiota transplantation (FMT) shows promise in modulating the immune system's function and alleviating the burdens associated with this condition.
Read This Paper